Ttbio Corp. (TPEX:6493)
Taiwan · Delayed Price · Currency is TWD 28.70
+1.00 (3.61%)
May 29, 2026, 1:24 PM CST
Ttbio Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 398.88 | 312.12 | 318.09 | 418.88 | 305.52 | |
Revenue Growth (YoY) | 27.80% | -1.88% | -24.06% | 37.11% | 70.72% |
Cost of Revenue | 328.54 | 239.34 | 239.67 | 296.35 | 215.07 |
Gross Profit | 70.34 | 72.77 | 78.42 | 122.53 | 90.45 |
Selling, General & Admin | 68.73 | 51.24 | 53.93 | 53.49 | 52.13 |
Research & Development | 22.4 | 23.82 | 25.36 | 30.68 | 26.06 |
Operating Expenses | 91.57 | 75.06 | 79.28 | 84.17 | 78.19 |
Operating Income | -21.23 | -2.29 | -0.86 | 38.36 | 12.26 |
Interest Expense | -5.45 | -4.93 | -2.3 | -1.58 | -1.18 |
Interest & Investment Income | 1 | 0.74 | 1.04 | 0.13 | 0.04 |
Currency Exchange Gain (Loss) | -2.33 | 3.62 | -2.3 | 6.98 | -0.03 |
Other Non Operating Income (Expenses) | 6.89 | 6.2 | 12.52 | 4.12 | 2.96 |
EBT Excluding Unusual Items | -21.13 | 3.34 | 8.09 | 48.01 | 14.05 |
Gain (Loss) on Sale of Assets | - | 0.06 | - | 0.3 | 0.07 |
Pretax Income | -21.13 | 3.4 | 8.09 | 48.31 | 14.12 |
Income Tax Expense | 0.17 | 0.81 | 1.41 | 8.51 | 2.59 |
Net Income | -21.3 | 2.59 | 6.68 | 39.8 | 11.53 |
Net Income to Common | -21.3 | 2.59 | 6.68 | 39.8 | 11.53 |
Net Income Growth | - | -61.21% | -83.22% | 245.06% | -74.86% |
Shares Outstanding (Basic) | 27 | 24 | 24 | 24 | 24 |
Shares Outstanding (Diluted) | 27 | 24 | 24 | 24 | 24 |
Shares Change (YoY) | 12.20% | -0.05% | -0.09% | 0.08% | -0.11% |
EPS (Basic) | -0.79 | 0.11 | 0.28 | 1.65 | 0.48 |
EPS (Diluted) | -0.79 | 0.11 | 0.28 | 1.65 | 0.48 |
EPS Growth | - | -61.21% | -83.17% | 244.08% | -74.76% |
Free Cash Flow | -49.02 | 18.47 | -37.86 | 13.51 | 32.37 |
Free Cash Flow Per Share | -1.82 | 0.77 | -1.57 | 0.56 | 1.34 |
Dividend Per Share | - | 0.250 | 0.300 | 1.250 | 0.500 |
Dividend Growth | - | -16.67% | -76.00% | 150.00% | -75.00% |
Gross Margin | 17.63% | 23.32% | 24.65% | 29.25% | 29.61% |
Operating Margin | -5.32% | -0.73% | -0.27% | 9.16% | 4.01% |
Profit Margin | -5.34% | 0.83% | 2.10% | 9.50% | 3.77% |
Free Cash Flow Margin | -12.29% | 5.92% | -11.90% | 3.23% | 10.59% |
EBITDA | 4.81 | 26.36 | 30.36 | 67.28 | 39.64 |
EBITDA Margin | 1.21% | 8.44% | 9.54% | 16.06% | 12.97% |
D&A For EBITDA | 26.04 | 28.64 | 31.22 | 28.92 | 27.38 |
EBIT | -21.23 | -2.29 | -0.86 | 38.36 | 12.26 |
EBIT Margin | -5.32% | -0.73% | -0.27% | 9.16% | 4.01% |
Effective Tax Rate | - | 23.78% | 17.46% | 17.62% | 18.32% |